Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Perneczky

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Dialogues in Clinical Neuroscience|October 15, 2019
Dementia prevention and reserve against neurodegenerative diseaseRobert Perneczky
Methods in Molecular Biology (Clifton, N.J.)|March 8, 2018
Population-Based Approaches to Alzheimer's Disease PreventionRobert Perneczky
Dialogues in Clinical Neuroscience|October 15, 2019
Dementia treatment versus preventionRobert Perneczky
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Alzheimer's Disease Prevention and Treatment Based on Population-Based ApproachesRobert Perneczky
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 27, 2010
Novel insights for the treatment of Alzheimer's diseaseAlexander Kurz, Robert Perneczky
International Psychogeriatrics|June 13, 2012
Dealing with uncertainty: biomarkers for the early detection of Alzheimer's diseaseRobert Perneczky, Alexander Kurz
Deutsche Medizinische Wochenschrift (1946)|April 25, 2022
[Diagnosing Alzheimer's dementia - a playground for academics or a sensible clinical measure?]Maia Tatò, Robert Perneczky
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 19, 2013
Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's diseaseRobert Perneczky, Panagiotis Alexopoulos,
Innere Medizin (Heidelberg, Germany)|April 17, 2024
[The monoclonal antibody gantenerumab in the treatment of early Alzheimer's disease]Robert Perneczky, , Sirka Nitschmann
Alzheimer'S & Dementia (New York, N. Y.)|April 28, 2025
Clinically meaningful benefit and real-world evidence in Alzheimer's disease research and careRobert Perneczky, Lutz Froelich
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Dialogues in Clinical Neuroscience|October 15, 2019
Dementia prevention and reserve against neurodegenerative diseaseRobert Perneczky
Methods in Molecular Biology (Clifton, N.J.)|March 8, 2018
Population-Based Approaches to Alzheimer's Disease PreventionRobert Perneczky
Dialogues in Clinical Neuroscience|October 15, 2019
Dementia treatment versus preventionRobert Perneczky
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Alzheimer's Disease Prevention and Treatment Based on Population-Based ApproachesRobert Perneczky
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 27, 2010
Novel insights for the treatment of Alzheimer's diseaseAlexander Kurz, Robert Perneczky
International Psychogeriatrics|June 13, 2012
Dealing with uncertainty: biomarkers for the early detection of Alzheimer's diseaseRobert Perneczky, Alexander Kurz
Deutsche Medizinische Wochenschrift (1946)|April 25, 2022
[Diagnosing Alzheimer's dementia - a playground for academics or a sensible clinical measure?]Maia Tatò, Robert Perneczky
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 19, 2013
Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's diseaseRobert Perneczky, Panagiotis Alexopoulos,
Innere Medizin (Heidelberg, Germany)|April 17, 2024
[The monoclonal antibody gantenerumab in the treatment of early Alzheimer's disease]Robert Perneczky, , Sirka Nitschmann
Alzheimer'S & Dementia (New York, N. Y.)|April 28, 2025
Clinically meaningful benefit and real-world evidence in Alzheimer's disease research and careRobert Perneczky, Lutz Froelich
Pageof 30